Coming Soon to the Coffee Aisle: Tariffs -- WSJ

Dow Jones
Jul 24, 2025

By Laura Cooper

Americans love their coffee. They're willing to pay for it. Tariffs could test that as the year goes on.

"The tariff impacts will become prominent," said Tim Cofer, chief executive of Keurig Dr Pepper, talking about coffee's second-half trajectory on the company's Thursday earnings call.

The U.S. is set to levy a 50% tariff on Brazilian goods-including coffee beans-from Aug. 1. Coffee beans from Brazil had already gotten more expensive, as poor weather pushed up prices at the end of last year.

Adding in inflation effects and consumer uncertainty, Keurig Dr Pepper said investors should expect subdued performance in its coffee business through the remainder of the year.

Keurig Dr Pepper on Thursday reported stronger results in its coffee segment. The company, which makes Keurig brewers and sells brands like Green Mountain Coffee, has increased prices this year and has another planned hike next month.

Shares of Keurig Dr Pepper slipped less than 1% in early trading Thursday.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

July 24, 2025 10:32 ET (14:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10